Marble meeting room at JK Capital's office, where mergers and acquisitions are negotiated

transactions

Public transactions advised by JK Capital

JK Capital lists 100 public transactions it has advised, across 12 sectors, including sell-side, buy-side and debt mandates. Most of the firm's mandates remain confidential and are not shown here.

Spanning a wide range of sectors, the transactions conducted by JK Capital include buy-side, sell-side and debt capital markets mandates.

Notice

Only public transactions are shown below.

Some operations conducted by JK Capital are not disclosed due to buyer and/or seller strategy.

Filter transactions1 active filter(s)

Sectors

Mandates

Selected transactions

42 transactions

Sell-SideHealthcare
Grupo Fleury (FLRY3) acquired Unilab, a clinical laboratory network in Atibaia and the surrounding region.
JK Capital acted as financial advisor to Unilab.
View transaction
Debt Capital MarketsHealthcare
Issuance of a Commercial Note by Grupo Cartão de Todos, in the amount of R$82.5 million.
JK Capital acted as exclusive financial advisor to Grupo Cartão de Todos.
View transaction
Sell-SideHealthcare
Grupo Fleury (FLRY3) acquired 100% of Confiance.
JK Capital acted as exclusive financial advisor to Confiance.
View transaction
Sell-SideHealthcare
Vision One acquired 100% of Centro de Oftalmologia Avançada (COA).
JK Capital acted as exclusive financial advisor to COA.
View transaction
Sell-SideHealthcare
Vision One acquired Hospital de Olhos de Florianópolis (HOF).
JK Capital acted as exclusive financial advisor to HOF.
View transaction
Sell-SideHealthcare
Care Plus completed the acquisition of Inpao Dental.
JK Capital acted as exclusive financial advisor to Inpao Dental.
View transaction
Sell-SideHealthcare
Vision One acquired Laser Ocular ABC.
JK Capital acted as exclusive financial advisor to Laser Ocular ABC.
View transaction
Sell-SideHealthcare
Vision One acquired Oftalmos Hospital da Visão.
JK Capital acted as exclusive financial advisor to Oftalmos.
View transaction
Sell-SideHealthcare
GEF Capital Partners acquired a minority stake in Clean Medical.
JK Capital acted as exclusive financial advisor to Clean Medical.
View transaction
Sell-SideHealthcare
Unity acquired a majority stake in Ressonance.
JK Capital acted as exclusive financial advisor to Ressonance.
View transaction
Sell-SideHealthcare
NotreDame Intermédica (GNDI3) acquired Hospital do Coração de Londrina.
JK Capital acted as exclusive financial advisor to Hospital do Coração de Londrina.
View transaction
Sell-SideHealthcare
Hospital Care, a portfolio company of private equity fund Crescera Investimentos and Abaporu fund, acquired a 60% stake in Grupo Austa.
JK Capital acted as exclusive financial advisor to Grupo Austa.
View transaction
Sell-SideHealthcare
Grupo Hapvida acquired Grupo São José.
JK Capital acted as exclusive financial advisor to Grupo São José.
View transaction
Buy-SideHealthcare
H.Hemo acquired Serviço de Hematologia e Hemoterapia.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired STS.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired Hemovida.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Sell-SideHealthcare
Premium acquired Auri Medicina Diagnóstica.
JK Capital acted as exclusive financial advisor to Auri Medicina Diagnóstica.
View transaction
Buy-SideHealthcare
Sanphar, a company belonging to the Austrian group ERBER Group, acquired 100% of IPEVE.
JK Capital acted as exclusive financial advisor to Sanphar / ERBER Group.
View transaction
Buy-SideHealthcare
H.Hemo acquired CTA.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Sell-SideHealthcare
Proparco made a capital investment in H.Hemo.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired Hemovalle.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired IHHC.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Sell-SideHealthcare
Ghelfond acquired Ecoimagem.
JK Capital acted as exclusive financial advisor to Ecoimagem.
View transaction
Buy-SideHealthcare
H.Hemo acquired a 51% stake in Unihemo.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired a 60.7% stake in Hemomed.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired a 51% stake in Hemoservice.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired a 51% stake in Hemoclínica.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired a 51% stake in Criobanco.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired CHCM.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired a 51% stake in SHSM.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired Hemoclínica.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Buy-SideHealthcare
H.Hemo acquired Fujisan.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Sell-SideHealthcare
Unique acquired a majority stake in Ultra-X.
JK Capital acted as exclusive financial advisor to Ultra-X.
View transaction
Buy-SideHealthcare
H.Hemo acquired Bioclínica.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Sell-SideHealthcare
2bCapital made a capital investment in H.Hemo.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Debt Capital MarketsHealthcare
Debt issuance in the amount of R$15 million.
JK Capital acted as exclusive financial advisor to H.Hemo.
View transaction
Sell-SideHealthcare
SIS Group acquired Vivace.
JK Capital acted as exclusive financial advisor to Vivace.
View transaction
Sell-SideHealthcare
Grupo Fleury (FLRY3) acquired Serdil.
JK Capital acted as exclusive financial advisor to Serdil.
View transaction
Sell-SideHealthcare
Ghelfond Diagnósticos acquired a majority stake in Grupo IMEDI.
JK Capital acted as exclusive financial advisor to Grupo IMEDI.
View transaction
Sell-SideHealthcare
Advised on a process for admitting new partners to Centro Diagnóstico por Imagem de Barretos.
View transaction
Sell-SideHealthcare
Advised on the shareholder restructuring among the partners of WM Diagnósticos por Imagem.
View transaction
Debt Capital MarketsHealthcare
Issuance of a Bank Credit Certificate.
JK Capital acted as exclusive financial advisor to Ecoimagem.
View transaction

Updated on 06 October 2026

Public transactions advised by JK Capital

Selected transactions

Grupo Fleury (FLRY3) acquired Unilab, a clinical laboratory network in Atibaia and the surrounding region.

Issuance of a Commercial Note by Grupo Cartão de Todos, in the amount of R$82.5 million.

Grupo Fleury (FLRY3) acquired 100% of Confiance.

Vision One acquired 100% of Centro de Oftalmologia Avançada (COA).

Vision One acquired Hospital de Olhos de Florianópolis (HOF).

Care Plus completed the acquisition of Inpao Dental.

Vision One acquired Laser Ocular ABC.

Vision One acquired Oftalmos Hospital da Visão.

GEF Capital Partners acquired a minority stake in Clean Medical.

Unity acquired a majority stake in Ressonance.

NotreDame Intermédica (GNDI3) acquired Hospital do Coração de Londrina.

Hospital Care, a portfolio company of private equity fund Crescera Investimentos and Abaporu fund, acquired a 60% stake in Grupo Austa.

Grupo Hapvida acquired Grupo São José.

H.Hemo acquired Serviço de Hematologia e Hemoterapia.

H.Hemo acquired STS.

H.Hemo acquired Hemovida.

Premium acquired Auri Medicina Diagnóstica.

Sanphar, a company belonging to the Austrian group ERBER Group, acquired 100% of IPEVE.

H.Hemo acquired CTA.

Proparco made a capital investment in H.Hemo.

H.Hemo acquired Hemovalle.

H.Hemo acquired IHHC.

Ghelfond acquired Ecoimagem.

H.Hemo acquired a 51% stake in Unihemo.

H.Hemo acquired a 60.7% stake in Hemomed.

H.Hemo acquired a 51% stake in Hemoservice.

H.Hemo acquired a 51% stake in Hemoclínica.

H.Hemo acquired a 51% stake in Criobanco.

H.Hemo acquired CHCM.

H.Hemo acquired a 51% stake in SHSM.

H.Hemo acquired Hemoclínica.

H.Hemo acquired Fujisan.

Unique acquired a majority stake in Ultra-X.

H.Hemo acquired Bioclínica.

2bCapital made a capital investment in H.Hemo.

Debt issuance in the amount of R$15 million.

SIS Group acquired Vivace.

Grupo Fleury (FLRY3) acquired Serdil.

Ghelfond Diagnósticos acquired a majority stake in Grupo IMEDI.

Advised on a process for admitting new partners to Centro Diagnóstico por Imagem de Barretos.

Advised on the shareholder restructuring among the partners of WM Diagnósticos por Imagem.

Issuance of a Bank Credit Certificate.